Regadenoson use in patients with chronic obstructive pulmonary disease: the state of current knowledge.

Int J Chron Obstruct Pulmon Dis · 2014 · PMC3904829 · PMID 24489466

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an apparent trendno p-value reported

Additionally, despite an apparent trend, these trials are not sufficiently powered to determine whether aminophylline administration following regadenoson can improve tolerability among patients with COPD/asthma.

also in 709 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.